FDA approves 1st-of-its-kind drug for rare blood disorder
The FDA has approved Mimrylo (rusfertide) to treat adults with polycythemia vera whose disease has not been adequately controlled with existing therapies. Mimrylo is the first approved treatment for polycythemia vera that mimics hepcidin, a hormone that regulates iron in the body, according to an Aug. 28 news release. The drug limits the iron available […] The post FDA approves 1st-of-its-kind drug for rare blood disorder appeared first on Becker's Hospital Review | Healthcare News &a...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.